Pulmonx Corporation (LUNG)
6.52
-0.30 (-4.40%)
At close: Mar 31, 2025, 12:34 PM
Pulmonx Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 83.79M | 68.67M | 53.66M | 48.42M | 32.73M | 32.59M | 20M |
| Cost of Revenue | 21.79M | 17.92M | 13.8M | 12.79M | 11.53M | 10.18M | 7.72M |
| Gross Profit | 62M | 50.75M | 39.87M | 35.63M | 21.2M | 22.41M | 12.29M |
| Operating Income | -57.7M | -61.94M | -58.64M | -47.3M | -32.33M | -17.84M | -15.05M |
| Interest Income | 5.06M | 5.57M | 1.53M | 400K | 213K | 432K | 21K |
| Pretax Income | -55.89M | -60.27M | -58.57M | -48.32M | -32.02M | -20.34M | -18.47M |
| Net Income | -56.39M | -60.84M | -58.92M | -48.66M | -32.23M | -20.7M | -18.48M |
| Selling & General & Admin | 102.14M | 94.61M | 83.11M | 69.87M | 46.07M | 34.2M | 20.35M |
| Research & Development | 17.57M | 18.08M | 15.4M | 13.06M | 7.46M | 6.05M | 6.99M |
| Other Expenses | n/a | n/a | -396K | -585K | 3.28M | -617K | -916K |
| Operating Expenses | 119.7M | 112.69M | 98.5M | 82.93M | 53.53M | 40.25M | 27.34M |
| Interest Expense | 3.51M | 3.23M | 1.07M | 829K | 3.18M | 2.32M | 2.52M |
| Selling & Marketing Expenses | n/a | 4.8M | 6.1M | 5.1M | 1.5M | 600K | 100K |
| Cost & Expenses | 141.49M | 130.61M | 112.3M | 95.72M | 65.06M | 50.43M | 35.06M |
| Income Tax | 500K | 571K | 353K | 343K | 213K | 363K | 12K |
| Shares Outstanding (Basic) | 39.11M | 37.97M | 37.1M | 36.13M | 35.69M | 35.43M | 20.71M |
| Shares Outstanding (Diluted) | 39.11M | 37.97M | 37.1M | 36.13M | 35.69M | 35.43M | 20.71M |
| EPS (Basic) | -1.44 | -1.6 | -1.59 | -1.35 | -0.9 | -0.58 | -0.89 |
| EPS (Diluted) | -1.44 | -1.6 | -1.59 | -1.35 | -0.9 | -0.58 | -0.89 |
| EBITDA | -57.7M | -55.09M | -55.99M | -46.62M | -28.44M | -16.82M | -15.68M |
| Depreciation & Amortization | 1.49M | 1.95M | 4M | 3.16M | 400K | 1.2M | 270K |